Literature DB >> 15544923

Paraoxonase 2 (PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH)-oxidase-dependent mechanism during monocytes differentiation into macrophages.

Maayan Shiner1, Bianca Fuhrman, Michael Aviram.   

Abstract

Paraoxonase 2 (PON2) is a member of the paraoxonases gene family. PON2 is ubiquitously present in cells, including macrophages, and it was shown to protect against cellular oxidative stress. The aim of the present study was to analyze mechanisms involved in PON2 expression during monocyte/macrophage differentiation. PON2 expression was analyzed in vitro in THP-1 cells differentiated with 1alpha,25-dihydroxyvitamin D3 and in vivo in mouse peritoneal macrophages (MPM) isolated at increasing time intervals after intraperitoneal thioglycollate injection. PON2 expression (mRNA and protein) and activity gradually increased during monocyte/macrophage differentiation, up to five fold and eight fold in vitro and in vivo, respectively. This effect was associated with a gradual increase in cellular superoxide anion production. Supplementation of vitamin E to Balb/C mice inhibited the reduced nicotinamide adenine dinuleotide phosphate (NADPH)-oxidase-dependent increase in cellular superoxide anion production by 50% and down-regulated PON2 mRNA expression and activity by 30 and 60%, respectively. Furthermore, PON2 expression was lower by nine fold in MPM isolated from P47(phox-/-) (inactive NADPH oxidase) mice, in comparison to MPM from control mice. PON2 expression was found to be regulated, at least in part, by the transcription factor AP-1, as suggested by decreased JDP2 (AP-1 repressor) protein expression in the nucleus and by decreased PON2 expression in the presence of a Jun N-terminal kinase inhibitor (SP600125). The present study demonstrates, for the first time, that PON2 expression increases in monocytes during their maturation into macrophage as a result of NADPH-oxidase activation, and this process is partly regulated by the transcription factor AP-1. PON2 stimulation may represent a compensatory mechanism against the increase in cellular superoxide anion production and atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15544923     DOI: 10.1016/j.freeradbiomed.2004.09.003

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  24 in total

1.  One enzyme, two functions: PON2 prevents mitochondrial superoxide formation and apoptosis independent from its lactonase activity.

Authors:  Sebastian Altenhöfer; Ines Witte; John F Teiber; Petra Wilgenbus; Andrea Pautz; Huige Li; Andreas Daiber; Heidrun Witan; Albrecht M Clement; Ulrich Förstermann; Sven Horke
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

Review 2.  Paraoxonase-2 (PON2) in brain and its potential role in neuroprotection.

Authors:  Lucio G Costa; Rian de Laat; Khoi Dao; Claudia Pellacani; Toby B Cole; Clement E Furlong
Journal:  Neurotoxicology       Date:  2013-09-04       Impact factor: 4.294

3.  Formation of a vitamin C conjugate of acrolein and its paraoxonase-mediated conversion into 5,6,7,8-tetrahydroxy-4-oxooctanal.

Authors:  Nicholas G Kesinger; Brandi L Langsdorf; Alexandre F Yokochi; Cristobal L Miranda; Jan F Stevens
Journal:  Chem Res Toxicol       Date:  2010-04-19       Impact factor: 3.739

4.  Paraoxonase 2 (PON2) in the mouse central nervous system: a neuroprotective role?

Authors:  Gennaro Giordano; Toby B Cole; Clement E Furlong; Lucio G Costa
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-23       Impact factor: 4.219

5.  PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death.

Authors:  E-M Schweikert; A Devarajan; I Witte; P Wilgenbus; J Amort; U Förstermann; A Shabazian; V Grijalva; D M Shih; R Farias-Eisner; J F Teiber; S T Reddy; S Horke
Journal:  Cell Death Differ       Date:  2012-03-23       Impact factor: 15.828

6.  Expression profiling reveals meiotic male germ cell mRNAs that are translationally up- and down-regulated.

Authors:  Naoko Iguchi; John W Tobias; Norman B Hecht
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

7.  Paraoxonases-1, -2 and -3: What are their functions?

Authors:  Clement E Furlong; Judit Marsillach; Gail P Jarvik; Lucio G Costa
Journal:  Chem Biol Interact       Date:  2016-05-26       Impact factor: 5.192

Review 8.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

9.  Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1.

Authors:  Mira Rosenblat; Raymond Coleman; Srinivasa T Reddy; Michael Aviram
Journal:  J Lipid Res       Date:  2008-12-16       Impact factor: 5.922

10.  Effect of quercetin on paraoxonase 2 levels in RAW264.7 macrophages and in human monocytes--role of quercetin metabolism.

Authors:  Christine Boesch-Saadatmandi; Renata Toedter Pospissil; Anne-Christin Graeser; Raffaella Canali; Inka Boomgaarden; Frank Doering; Siegfried Wolffram; Sarah Egert; Manfred James Mueller; Gerald Rimbach
Journal:  Int J Mol Sci       Date:  2009-09-23       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.